{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:54:32Z","timestamp":1792065272018,"version":"4.4.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The amygdala is highly vulnerable to protein aggregation and heavily affected in Lewy body diseases (LBDs). However, vulnerability might vary per amygdalar nucleus and it is unclear if the pattern of vulnerability across the nuclei differs between types of protein aggregation and between LBDs. In this study, we aimed to assess the vulnerability of amygdalar nuclei to multiple types of protein aggregation across LBDs. Post-mortem amygdala tissue of donors with incidental LBD (iLBD, n\u2009=\u20096), Parkinson\u2019s disease (PD; n\u2009=\u200918), dementia with Lewy bodies (DLB; n\u2009=\u20099) and Alzheimer\u2019s disease with Lewy bodies (AD\u2009+\u2009LB; n\u2009=\u200915) was immunostained with antibodies against alpha-synuclein (aSyn; EP1536Y and 5G4), amyloid beta (A\u03b2; 4G8), phosphorylated tau (p-tau; AT8) and phosphorylated TDP-43 (p-TDP-43; 11\u20139), and quantitatively analyzed using QuPath. Neuronal and astrocytic aSyn pathology were most pronounced in the parahippocampal-amygdaloid transition area (PHA) and the basal nucleus, a pattern shared by all disease groups. Vulnerability to A\u03b2 pathology varied per group but was highest in the PHA in AD\u2009+\u2009LB, whereas diffuse plaques were most common in the accessory basal nucleus. The PHA of DLB and both the basal and accessory basal nucleus of AD\u2009+\u2009LB cases were most susceptible to p-tau pathology, with fine granular cytoplasmic neuronal tau inclusions being mostly observed in the basal nucleus and neurofibrillary tangles in the accessory basal nucleus. The nuclei in the ventromedial part of the amygdala (PHA, ventral part of the basal nucleus, and cortical nucleus) were found to be hotspots for protein aggregation across LBDs. aSyn pathology in these nuclei predominantly correlated with dementia, hallucinations and anxiety. Our results show that amygdalar nuclei vulnerability differs per protein aggregate and disease entity, although the PHA, basal nucleus and cortical nucleus are generally more vulnerable. Together, our study provides a deeper insight into the selective vulnerability of amygdalar nuclei to protein aggregates and their relation to clinical characteristics in LBDs.<\/jats:p>","DOI":"10.1186\/s40478-026-02381-0","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:57:59Z","timestamp":1784591879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Amygdalar nuclei vulnerability to protein aggregates in Lewy body diseases"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8602-5075","authenticated-orcid":false,"given":"Natasja A. C.","family":"Deshayes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janna","family":"van Wetering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Wesseling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floris","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Ingrassia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvon","family":"Galis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Jonkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke J. M.","family":"Rozemuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma D. J.","family":"van de Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"2381_CR1","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/mds.22971","volume":"25","author":"CH Adler","year":"2010","unstructured":"Adler CH, Connor DJ, Hentz JG, Sabbagh MN, Caviness JN, Shill HA et al (2010) Incidental Lewy body disease: clinical comparison to a control cohort. Mov Disord 25:642\u2013646. https:\/\/doi.org\/10.1002\/mds.22971","journal-title":"Mov Disord"},{"key":"2381_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1750-3639.2008.00147.x","volume":"18","author":"I Alafuzoff","year":"2008","unstructured":"Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H et al (2008) Staging of neurofibrillary pathology in Alzheimer\u2019s disease: a study of the BrainNet Europe Consortium. Brain Pathol 18:484\u2013496. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00147.x","journal-title":"Brain Pathol"},{"key":"2381_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00401-009-0523-2","volume":"117","author":"I Alafuzoff","year":"2009","unstructured":"Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I et al (2009) Staging\/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 117:635\u2013652. https:\/\/doi.org\/10.1007\/s00401-009-0523-2","journal-title":"Acta Neuropathol"},{"key":"2381_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00401-009-0485-4","volume":"117","author":"I Alafuzoff","year":"2009","unstructured":"Alafuzoff I, Thal DR, Arzberger T, Bogdanovic N, Al-Sarraj S, Bodi I et al (2009) Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol 117:309\u2013320. https:\/\/doi.org\/10.1007\/s00401-009-0485-4","journal-title":"Acta Neuropathol"},{"key":"2381_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fernandez JA, Dombrowski Y, McArt DG, Dunne PD et al (2017) QuPath: open source software for digital pathology image analysis. Sci Rep 7:16878. https:\/\/doi.org\/10.1038\/s41598-017-17204-5","journal-title":"Sci Rep"},{"key":"2381_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1212\/WNL.0000000000001171","volume":"84","author":"EE Benarroch","year":"2015","unstructured":"Benarroch EE (2015) The amygdala: functional organization and involvement in neurologic disorders. Neurology 84:313\u2013324. https:\/\/doi.org\/10.1212\/WNL.0000000000001171","journal-title":"Neurology"},{"key":"2381_CR7","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00702-023-02633-6","volume":"130","author":"P Borghammer","year":"2023","unstructured":"Borghammer P (2023) The brain-first vs. body-first model of Parkinson\u2019s disease with comparison to alternative models. J Neural Transm (Vienna) 130:737\u2013753. https:\/\/doi.org\/10.1007\/s00702-023-02633-6","journal-title":"J Neural Transm (Vienna)"},{"key":"2381_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/bf00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259. https:\/\/doi.org\/10.1007\/bf00308809","journal-title":"Acta Neuropathol"},{"key":"2381_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/bf00296485","volume":"88","author":"H Braak","year":"1994","unstructured":"Braak H, Braak E, Yilmazer D, de Vos RA, Jansen EN, Bohl J et al (1994) Amygdala pathology in Parkinson\u2019s disease. Acta Neuropathol 88:493\u2013500. https:\/\/doi.org\/10.1007\/bf00296485","journal-title":"Acta Neuropathol"},{"key":"2381_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"key":"2381_CR11","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1212\/wnl.38.11.1694","volume":"38","author":"HR Brashear","year":"1988","unstructured":"Brashear HR, Godec MS, Carlsen J (1988) The distribution of neuritic plaques and acetylcholinesterase staining in the amygdala in Alzheimer\u2019s disease. Neurology 38:1694\u20131699. https:\/\/doi.org\/10.1212\/wnl.38.11.1694","journal-title":"Neurology"},{"key":"2381_CR12","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1212\/wnl.49.6.1570","volume":"49","author":"A Churchyard","year":"1997","unstructured":"Churchyard A, Lees AJ (1997) The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson\u2019s disease. Neurology 49:1570\u20131576. https:\/\/doi.org\/10.1212\/wnl.49.6.1570","journal-title":"Neurology"},{"key":"2381_CR13","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1002\/cne.24468","volume":"526","author":"V Delic","year":"2018","unstructured":"Delic V, Chandra S, Abdelmotilib H, Maltbie T, Wang S, Kem D et al (2018) Sensitivity and specificity of phospho-Ser129 alpha-synuclein monoclonal antibodies. J Comp Neurol 526:1978\u20131990. https:\/\/doi.org\/10.1002\/cne.24468","journal-title":"J Comp Neurol"},{"key":"2381_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.47.1.56","volume":"47","author":"MM Esiri","year":"1984","unstructured":"Esiri MM, Wilcock GK (1984) The olfactory bulbs in Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 47:56\u201360. https:\/\/doi.org\/10.1136\/jnnp.47.1.56","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2381_CR15","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/jnen\/nlx054","volume":"76","author":"A Flores-Cuadrado","year":"2017","unstructured":"Flores-Cuadrado A, Ubeda-Banon I, Saiz-Sanchez D, Martinez-Marcos A (2017) alpha-Synucleinopathy in the Human Amygdala in Parkinson Disease: Differential Vulnerability of Somatostatin- and Parvalbumin-Expressing Neurons. J Neuropathol Exp Neurol 76:754\u2013758. https:\/\/doi.org\/10.1093\/jnen\/nlx054","journal-title":"J Neuropathol Exp Neurol"},{"key":"2381_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fnagi.2015.00234","volume":"7","author":"KH Franks","year":"2015","unstructured":"Franks KH, Chuah MI, King AE, Vickers JC (2015) Connectivity of pathology: the olfactory system as a model for network-driven mechanisms of Alzheimer\u2019s disease pathogenesis. Front Aging Neurosci 7:234. https:\/\/doi.org\/10.3389\/fnagi.2015.00234","journal-title":"Front Aging Neurosci"},{"key":"2381_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neuroscience.2012.03.040","volume":"212","author":"JL Fudge","year":"2012","unstructured":"Fudge JL, deCampo DM, Becoats KT (2012) Revisiting the hippocampal-amygdala pathway in primates: association with immature-appearing neurons. Neuroscience 212:104\u2013119. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.03.040","journal-title":"Neuroscience"},{"key":"2381_CR18","first-page":"1","volume":"19","author":"F Gallyas","year":"1971","unstructured":"Gallyas F (1971) Silver staining of Alzheimer\u2019s neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung 19:1\u20138","journal-title":"Acta Morphol Acad Sci Hung"},{"key":"2381_CR19","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41586-024-07680-x","volume":"631","author":"MAG Gilbert","year":"2024","unstructured":"Gilbert MAG, Fatima N, Jenkins J, O\u2019Sullivan TJ, Schertel A, Halfon Y et al (2024) CryoET of beta-amyloid and tau within postmortem Alzheimer\u2019s disease brain. Nature 631:913\u2013919. https:\/\/doi.org\/10.1038\/s41586-024-07680-x","journal-title":"Nature"},{"key":"2381_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13180","volume":"33","author":"M Gonzalez-Rodriguez","year":"2023","unstructured":"Gonzalez-Rodriguez M, Villar-Conde S, Astillero-Lopez V, Villanueva-Anguita P, Ubeda-Banon I, Flores-Cuadrado A et al (2023) Human amygdala involvement in Alzheimer\u2019s disease revealed by stereological and dia-PASEF analysis. Brain Pathol 33:e13180. https:\/\/doi.org\/10.1111\/bpa.13180","journal-title":"Brain Pathol"},{"key":"2381_CR21","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","volume":"10","author":"RL Hamilton","year":"2000","unstructured":"Hamilton RL (2000) Lewy bodies in Alzheimer\u2019s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 10:378\u2013384. https:\/\/doi.org\/10.1111\/j.1750-3639.2000.tb00269.x","journal-title":"Brain Pathol"},{"key":"2381_CR22","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1093\/brain\/awf251","volume":"125","author":"AJ Harding","year":"2002","unstructured":"Harding AJ, Stimson E, Henderson JM, Halliday GM (2002) Clinical correlates of selective pathology in the amygdala of patients with Parkinson\u2019s disease. Brain 125:2431\u20132445. https:\/\/doi.org\/10.1093\/brain\/awf251","journal-title":"Brain"},{"key":"2381_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106101","volume":"122","author":"J Horsager","year":"2024","unstructured":"Horsager J, Borghammer P (2024) Brain-first vs. body-first Parkinson\u2019s disease: an update on recent evidence. Parkinsonism Relat Disord 122:106101. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106101","journal-title":"Parkinsonism Relat Disord"},{"key":"2381_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1385\/jmn:17:2:225","volume":"17","author":"PT Kotzbauer","year":"2001","unstructured":"Kotzbauer PT, Trojanowsk JQ, Lee VM (2001) Lewy body pathology in Alzheimer\u2019s disease. J Mol Neurosci 17:225\u2013232. https:\/\/doi.org\/10.1385\/jmn:17:2:225","journal-title":"J Mol Neurosci"},{"key":"2381_CR25","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1038\/s41467-025-59085-7","volume":"16","author":"S Koutarapu","year":"2025","unstructured":"Koutarapu S, Ge J, Dulewicz M, Srikrishna M, Szadziewska A, Wood J et al (2025) Chemical imaging delineates Abeta plaque polymorphism across the Alzheimer\u2019s disease spectrum. Nat Commun 16:3889. https:\/\/doi.org\/10.1038\/s41467-025-59085-7","journal-title":"Nat Commun"},{"key":"2381_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","volume":"131","author":"GG Kovacs","year":"2016","unstructured":"Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H et al (2016) Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol 131:87\u2013102. https:\/\/doi.org\/10.1007\/s00401-015-1509-x","journal-title":"Acta Neuropathol"},{"key":"2381_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-012-0964-x","volume":"124","author":"GG Kovacs","year":"2012","unstructured":"Kovacs GG, Wagner U, Dumont B, Pikkarainen M, Osman AA, Streichenberger N et al (2012) An antibody with high reactivity for disease-associated alpha-synuclein reveals extensive brain pathology. Acta Neuropathol 124:37\u201350. https:\/\/doi.org\/10.1007\/s00401-012-0964-x","journal-title":"Acta Neuropathol"},{"key":"2381_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/0306-4522(90)90408-v","volume":"37","author":"LJ Kromer Vogt","year":"1990","unstructured":"Kromer Vogt LJ, Hyman BT, Van Hoesen GW, Damasio AR (1990) Pathological alterations in the amygdala in Alzheimer\u2019s disease. Neuroscience 37:377\u2013385. https:\/\/doi.org\/10.1016\/0306-4522(90)90408-v","journal-title":"Neuroscience"},{"key":"2381_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00825-9","volume":"10","author":"MA Laansma","year":"2024","unstructured":"Laansma MA, Zhao Y, van Heese EM, Bright JK, Owens-Walton C, Al-Bachari S et al (2024) A worldwide study of subcortical shape as a marker for clinical staging in Parkinson\u2019s disease. NPJ Parkinsons Dis 10:223. https:\/\/doi.org\/10.1038\/s41531-024-00825-9","journal-title":"NPJ Parkinsons Dis"},{"key":"2381_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00547-4","volume":"9","author":"TT Lai","year":"2023","unstructured":"Lai TT, Gericke B, Feja M, Conoscenti M, Zelikowsky M, Richter F (2023) Anxiety in synucleinopathies: neuronal circuitry, underlying pathomechanisms and current therapeutic strategies. NPJ Parkinsons Dis 9:97. https:\/\/doi.org\/10.1038\/s41531-023-00547-4","journal-title":"NPJ Parkinsons Dis"},{"key":"2381_CR31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.bbi.2025.04.025","volume":"128","author":"TT Lai","year":"2025","unstructured":"Lai TT, Xiang W, Stanojlovic M, Kaufer C, Feja M, Lau K et al (2025) The basolateral amygdala and striatum propagate alpha-synuclein pathology causing increased fear response in a Parkinson\u2019s disease model. Brain Behav Immun 128:469\u2013486. https:\/\/doi.org\/10.1016\/j.bbi.2025.04.025","journal-title":"Brain Behav Immun"},{"key":"2381_CR32","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/nn.2904","volume":"14","author":"J Li","year":"2011","unstructured":"Li J, Schiller D, Schoenbaum G, Phelps EA, Daw ND (2011) Differential roles of human striatum and amygdala in associative learning. Nat Neurosci 14:1250\u20131252. https:\/\/doi.org\/10.1038\/nn.2904","journal-title":"Nat Neurosci"},{"key":"2381_CR33","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1212\/01.wnl.0000230161.28299.3c","volume":"67","author":"OL Lopez","year":"2006","unstructured":"Lopez OL, Becker JT, Sweet RA, Martin-Sanchez FJ, Hamilton RL (2006) Lewy bodies in the amygdala increase risk for major depression in subjects with Alzheimer disease. Neurology 67:660\u2013665. https:\/\/doi.org\/10.1212\/01.wnl.0000230161.28299.3c","journal-title":"Neurology"},{"key":"2381_CR34","unstructured":"Mai J, Assheueer J, and Paxinos G, Atlas of the Human Brain. 2000."},{"key":"2381_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89:88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058","journal-title":"Neurology"},{"key":"2381_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/B978-0-12-823493-8.00017-1","volume":"187","author":"OC Meisner","year":"2022","unstructured":"Meisner OC, Nair A, Chang SWC (2022) Amygdala connectivity and implications for social cognition and disorders. Handb Clin Neurol 187:381\u2013403. https:\/\/doi.org\/10.1016\/B978-0-12-823493-8.00017-1","journal-title":"Handb Clin Neurol"},{"key":"2381_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311. https:\/\/doi.org\/10.1007\/s00401-011-0910-3","journal-title":"Acta Neuropathol"},{"key":"2381_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/psyg.70097","volume":"25","author":"IP Moreira","year":"2025","unstructured":"Moreira IP, Vieira-Coelho MA, Guimaraes J (2025) Dopamine system dysfunction in Alzheimer\u2019s disease. Psychogeriatrics 25:e70097. https:\/\/doi.org\/10.1111\/psyg.70097","journal-title":"Psychogeriatrics"},{"key":"2381_CR39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/jnen\/nlx099","volume":"77","author":"PT Nelson","year":"2018","unstructured":"Nelson PT, Abner EL, Patel E, Anderson S, Wilcock DM, Kryscio RJ et al (2018) The amygdala as a locus of pathologic misfolding in neurodegenerative diseases. J Neuropathol Exp Neurol 77:2\u201320. https:\/\/doi.org\/10.1093\/jnen\/nlx099","journal-title":"J Neuropathol Exp Neurol"},{"key":"2381_CR40","doi-asserted-by":"publisher","unstructured":"Nikolenko VN, Oganesyan MV, Rizaeva NA, Kudryashova VA, Nikitina AT, Pavliv MP, et al (2020) Amygdala: Neuroanatomical and Morphophysiological Features in Terms of Neurological and Neurodegenerative Diseases. Brain Sci 10: https:\/\/doi.org\/10.3390\/brainsci10080502.","DOI":"10.3390\/brainsci10080502"},{"key":"2381_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2021.752320","volume":"15","author":"T Noto","year":"2021","unstructured":"Noto T, Zhou G, Yang Q, Lane G, Zelano C (2021) Human primary olfactory amygdala subregions form distinct functional networks, suggesting distinct olfactory functions. Front Syst Neurosci 15:752320. https:\/\/doi.org\/10.3389\/fnsys.2021.752320","journal-title":"Front Syst Neurosci"},{"key":"2381_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-025-01944-x","volume":"13","author":"M Otero-Jimenez","year":"2025","unstructured":"Otero-Jimenez M, Wojewska MJ, Binding LP, Jogaudaite S, Gray-Rodriguez S, Young AL et al (2025) Neuropathological stages of neuronal, astrocytic and oligodendrocytic alpha-synuclein pathology in Parkinson\u2019s disease. Acta Neuropathol Commun 13:25. https:\/\/doi.org\/10.1186\/s40478-025-01944-x","journal-title":"Acta Neuropathol Commun"},{"key":"2381_CR43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.parkreldis.2005.10.005","volume":"12","author":"S Papapetropoulos","year":"2006","unstructured":"Papapetropoulos S, McCorquodale DS, Gonzalez J, Jean-Gilles L, Mash DC (2006) Cortical and amygdalar Lewy body burden in Parkinson\u2019s disease patients with visual hallucinations. Parkinsonism Relat Disord 12:253\u2013256. https:\/\/doi.org\/10.1016\/j.parkreldis.2005.10.005","journal-title":"Parkinsonism Relat Disord"},{"key":"2381_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev.psych.56.091103.070234","volume":"57","author":"EA Phelps","year":"2006","unstructured":"Phelps EA (2006) Emotion and cognition: insights from studies of the human amygdala. Annu Rev Psychol 57:27\u201353. https:\/\/doi.org\/10.1146\/annurev.psych.56.091103.070234","journal-title":"Annu Rev Psychol"},{"key":"2381_CR45","doi-asserted-by":"publisher","first-page":"7379","DOI":"10.1523\/JNEUROSCI.0740-09.2009","volume":"29","author":"MW Pitts","year":"2009","unstructured":"Pitts MW, Todorovic C, Blank T, Takahashi LK (2009) The central nucleus of the amygdala and corticotropin-releasing factor: insights into contextual fear memory. J Neurosci 29:7379\u20137388. https:\/\/doi.org\/10.1523\/JNEUROSCI.0740-09.2009","journal-title":"J Neurosci"},{"key":"2381_CR46","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1001\/archneur.61.12.1915","volume":"61","author":"A Popescu","year":"2004","unstructured":"Popescu A, Lippa CF, Lee VM, Trojanowski JQ (2004) Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions. Arch Neurol 61:1915\u20131919. https:\/\/doi.org\/10.1001\/archneur.61.12.1915","journal-title":"Arch Neurol"},{"key":"2381_CR47","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","volume":"10","author":"S Ramesh","year":"2023","unstructured":"Ramesh S, Arachchige A (2023) Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: a review of the literature. AIMS Neurosci 10:200\u2013231. https:\/\/doi.org\/10.3934\/Neuroscience.2023017","journal-title":"AIMS Neurosci"},{"key":"2381_CR48","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3233\/JAD-170104","volume":"58","author":"A Raunio","year":"2017","unstructured":"Raunio A, Myllykangas L, Kero M, Polvikoski T, Paetau A, Oinas M (2017) Amygdala alpha-Synuclein Pathology in the Population-Based Vantaa 85+ Study. J Alzheimers Dis 58:669\u2013674. https:\/\/doi.org\/10.3233\/JAD-170104","journal-title":"J Alzheimers Dis"},{"key":"2381_CR49","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/0306-4522(90)90439-b","volume":"36","author":"AF Sadikot","year":"1990","unstructured":"Sadikot AF, Parent A (1990) The monoaminergic innervation of the amygdala in the squirrel monkey: an immunohistochemical study. Neuroscience 36:431\u2013447. https:\/\/doi.org\/10.1016\/0306-4522(90)90439-b","journal-title":"Neuroscience"},{"key":"2381_CR50","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1152\/physrev.00002.2003","volume":"83","author":"P Sah","year":"2003","unstructured":"Sah P, Faber ES, Lopez De Armentia M, Power J (2003) The amygdaloid complex: anatomy and physiology. Physiol Rev 83:803\u2013834. https:\/\/doi.org\/10.1152\/physrev.00002.2003","journal-title":"Physiol Rev"},{"key":"2381_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00401-005-0003-2","volume":"111","author":"HA Sahin","year":"2006","unstructured":"Sahin HA, Emre M, Ziabreva I, Perry E, Celasun B, Perry R (2006) The distribution pattern of pathology and cholinergic deficits in amygdaloid complex in Alzheimer\u2019s disease and dementia with Lewy bodies. Acta Neuropathol 111:115\u2013125. https:\/\/doi.org\/10.1007\/s00401-005-0003-2","journal-title":"Acta Neuropathol"},{"key":"2381_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70904","volume":"21","author":"H Sekiya","year":"2025","unstructured":"Sekiya H, Franke L, Ono D, DeTure M, Ross OA, Day GS et al (2025) Association between visual hallucinations and alpha-synuclein oligomers in patients with dementia with Lewy bodies. Alzheimers Dement 21:e70904. https:\/\/doi.org\/10.1002\/alz.70904","journal-title":"Alzheimers Dement"},{"key":"2381_CR53","doi-asserted-by":"publisher","unstructured":"Simic G, Tkalcic M, Vukic V, Mulc D, Spanic E, Sagud M, et al (2021) Understanding Emotions: Origins and Roles of the Amygdala. Biomolecules 11: https:\/\/doi.org\/10.3390\/biom11060823.","DOI":"10.3390\/biom11060823"},{"key":"2381_CR54","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s40478-019-0787-2","volume":"7","author":"ZA Sorrentino","year":"2019","unstructured":"Sorrentino ZA, Goodwin MS, Riffe CJ, Dhillon JS, Xia Y, Gorion KM et al (2019) Unique alpha-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression. Acta Neuropathol Commun 7:142. https:\/\/doi.org\/10.1186\/s40478-019-0787-2","journal-title":"Acta Neuropathol Commun"},{"key":"2381_CR55","doi-asserted-by":"publisher","first-page":"9799","DOI":"10.1523\/JNEUROSCI.1787-16.2017","volume":"37","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Obeso JA, Halliday GM (2017) Parkinson\u2019s disease is not simply a prion disorder. J Neurosci 37:9799\u20139807. https:\/\/doi.org\/10.1523\/JNEUROSCI.1787-16.2017","journal-title":"J Neurosci"},{"key":"2381_CR56","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.brainresbull.2022.10.006","volume":"190","author":"DR Thal","year":"2022","unstructured":"Thal DR, Tome SO (2022) The central role of tau in Alzheimer\u2019s disease: from neurofibrillary tangle maturation to the induction of cell death. Brain Res Bull 190:204\u2013217. https:\/\/doi.org\/10.1016\/j.brainresbull.2022.10.006","journal-title":"Brain Res Bull"},{"key":"2381_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-023-01688-6","volume":"11","author":"W Tsering","year":"2023","unstructured":"Tsering W, Hery GP, Phillips JL, Lolo K, Bathe T, Villareal JA et al (2023) Transformation of non-neuritic into neuritic plaques during AD progression drives cortical spread of tau pathology via regenerative failure. Acta Neuropathol Commun 11:190. https:\/\/doi.org\/10.1186\/s40478-023-01688-6","journal-title":"Acta Neuropathol Commun"},{"key":"2381_CR58","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0197-4580(91)90063-p","volume":"12","author":"JW Unger","year":"1991","unstructured":"Unger JW, Lapham LW, McNeill TH, Eskin TA, Hamill RW (1991) The amygdala in Alzheimer\u2019s disease: neuropathology and Alz 50 immunoreactivity. Neurobiol Aging 12:389\u2013399. https:\/\/doi.org\/10.1016\/0197-4580(91)90063-p","journal-title":"Neurobiol Aging"},{"key":"2381_CR59","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00401-023-02657-y","volume":"147","author":"BL van der Gaag","year":"2024","unstructured":"van der Gaag BL, Deshayes NAC, Breve JJP, Bol J, Jonker AJ, Hoozemans JJM et al (2024) Distinct tau and alpha-synuclein molecular signatures in Alzheimer\u2019s disease with and without Lewy bodies and Parkinson\u2019s disease with dementia. Acta Neuropathol 147:14. https:\/\/doi.org\/10.1007\/s00401-023-02657-y","journal-title":"Acta Neuropathol"},{"key":"2381_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100673","volume":"22","author":"S Villar-Conde","year":"2023","unstructured":"Villar-Conde S, Astillero-Lopez V, Gonzalez-Rodriguez M, Saiz-Sanchez D, Martinez-Marcos A, Ubeda-Banon I et al (2023) Synaptic involvement of the human amygdala in Parkinson\u2019s disease. Mol Cell Proteomics 22:100673. https:\/\/doi.org\/10.1016\/j.mcpro.2023.100673","journal-title":"Mol Cell Proteomics"},{"key":"2381_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/biom13091336","author":"SM Wang","year":"2023","unstructured":"Wang SM, Kang DW, Um YH, Kim S, Lee CU, Lim HK (2023) Olfactory dysfunction is associated with cerebral amyloid deposition and cognitive function in the trajectory of Alzheimer\u2019s disease. Biomolecules. https:\/\/doi.org\/10.3390\/biom13091336","journal-title":"Biomolecules"},{"key":"2381_CR62","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/B978-0-12-374236-0.10022-7","volume-title":"The human nervous system","author":"DM Yilmazer-Hanke","year":"2012","unstructured":"Yilmazer-Hanke DM (2012) Amygdala. The human nervous system. Elsevier Inc, pp 759\u2013834"},{"key":"2381_CR63","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.biopsych.2020.12.026","volume":"89","author":"WH Zhang","year":"2021","unstructured":"Zhang WH, Zhang JY, Holmes A, Pan BX (2021) Amygdala circuit substrates for stress adaptation and adversity. Biol Psychiatry 89:847\u2013856. https:\/\/doi.org\/10.1016\/j.biopsych.2020.12.026","journal-title":"Biol Psychiatry"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02381-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02381-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02381-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:15:00Z","timestamp":1792062900000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02381-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2381"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02381-0","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All donors or their next of kin signed a written informed consent for brain donation and the use of brain tissue as well as medical records for research purposes. The procedures used by the NBB and NABCA for autopsy and tissue collection were approved by the Medical Ethical Committee of Amsterdam UMC (formerly known as VUmc; NBB 2009.148; NABCA 2018.150).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consented to the publication of this manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"216"}}